Skip to main content
. 2016 Apr-Jun;10(2):134–142. doi: 10.1590/S1980-5764-2016DN1002009

Table 5. Means and standard deviations for items on self-evaluation scale performed before experiment (pre-treatment) and after the battery of tests (post-treatment).

Bodily Symptoms Scale (BSS) Methylphenidate F/H P
Placebo 10 mg 20 mg 40 mg
Pre-Treatment Physical exhaustion 29.46 ± 22.57 20.57 ± 23.52 38.63 ± 29.62 29.53 ± 30.69 0.67 0.57
Headache 5.13 ± 11 2.3 ± 3.54 1.42 ± 4.26 4.81 ± 11.76 0.41 0.74
Dizziness 10.14 ± 21.05 0.86 ± 1.83 10.82 ± 27.37 7.26 ± 13.67 0.53 0.65
Trembling 8.25 ± 15.13 6.89 ± 12.42 3.6 ± 6.99 4.99 ± 9.45 0.29 0.83
Weakness 9.15 ± 13.75 6.32 ± 10.37 0.86 ± 2.6 2.14 ± 3.74 5.05(H) 0.16
Muscular Tension 19.5 ± 17.83 22.02 ± 21.65 6.71 ± 5.72 8.97 ± 20.88 1.64 0.19
Nausea 1.36 ± 4.08 1.29 ± 2.33 6.41 ± 19.23 1 ± 2.2 1.31(H) 0.72
Dry mouth 51.05 ± 26.37 54.64 ± 35,52 59.82 ± 29.98 67 ± 26.52 0.48 0.69
Sweat 24.55 ± 31 21.1 ± 29.09 12.04 ± 17.27 11.83 ± 30.74 0.48 0.69
Blurred vision 31.67 ± 31.07 23.53 ± 29.79 24.78 ± 25.95 27.72 ± 24.66 0.15 0.92
Palpitation 4.57 ± 10.41 12.73 ± 16.29 13.32 ± 22.65 15.61 ± 29.06 0.48 0.69
Difficulty breathing 1.57 ± 3.14 7 ± 14.35 2.56 ± 5.43 0.67 ± 1.36 0.87(H) 0.83
Difficulty walking 3.13 ± 6.99 2.42 ± 3.26 5.27 ± 15.81 0.82 ± 1.63 0.39 0.75
Agitation 25.62 ± 25.91 28.3 ± 27.58 28.86 ± 20.41 29.2 ± 27.89 0.03 0.99
Motor Coordination 90.67 ± 15.29 91.41 ± 10.83 91.29 ± 20.58 96.72 ± 8.48 0.33 0.79
Hearing 78.33 ± 39.23 95.38 ± 12.47 93.16 ± 20.51 99.13 ± 1.7 1.60(H) 0.65
Difficulty speaking 17.01 ± 32.39 5.86 ± 7.92 1.99 ± 5.98 3.24 ± 7.13 3.31(H) 0,34
General wellbeing 67,48 ± 38,46 92,23 ± 12,01 78,64 ± 32,56 90,88 ± 15,82 1,78(H) 0,61
Post-Treatment Physical exhaustion 45.21 ± 16.82 17.02 ± 24.1 39.37 ± 33.5 33.45 ± 19.61 2.24 0.10
Headache 13.67 ± 24.32 8.92 ± 19.51 3.41 ± 8.13 0.85 ± 1.81 3.36(H) 0.33
Dizziness 9.98 ± 23.87 9.65 ± 21.08 11.12 ± 28.18 2.84 ± 4.98 0.27 0.84
Trembling 10.11 ± 21.47 1,42 ± 1.75 3.16 ± 5.19 7.26 ± 15.26 0.12(H) 0.98
Weakness 13.72 ± 22.27 7.99 ± 13.6 12.84 ± 28.32 6.55 ± 13.15 0.27 0.84
Muscular Tension 12.71 ± 15.66 27.15 ± 24.33 11.14 ± 11.52 15.82 ± 21.45 2.64(H) 0.45
Nausea 2.85 ± 4.39 2.14 ± 2.13 7.12 ± 21.36 0 ± 0 6.79(H) 0.07
Dry mouth 66.6 ± 29.31 69.33 ± 19.68 62.25 ± 29.79 71.71 ± 28.45 0.20 0.89
Sweating 9.02 ± 10.14 23.58 ± 33.77 19.97 ± 26.33 6.83 ± 20.51 3.65(H) 0.30
Blurred vision 17.63 ± 23.88 31.58 ± 28.72 28.96 ± 21.68 28.71 ± 30.84 0.49 0.69
Palpitation 11.34 ± 20.66 20.58 ± 24.2 5.98 ± 16.55 16.09 ± 21.64 0.80 0.49
Difficulty breathing 7.12 ± 19.52 12.68 ± 22.29 4.7 ± 10.21 0 ± 0 6.74(H) 0.08
Difficulty walking 9.98 ± 22.08 4.14 ± 7.18 6.12 ± 17.43 0.43 ± 1.3 0.67(H) 0.57
Agitation 31.94 ± 29.54 30.44 ± 25.34 19.13 ± 20.93 30.53 ± 24.12 0.50 0.68
Motor Coordination 80.43 ± 21.62 83.13 ± 21.35 80.63 ± 24.83 89.74 ± 19.14 0.35 0.78
Hearing 92.42 ± 13.02 94.7 ± 6.78 86.03 ± 30.91 99.71 ± 0.86 4.10(H) 0.25
Difficulty speaking 11.45 ± 17.93 8.43 ± 9.73 8.83 ± 26.01 0.56 ± 1.7 0.72 0.54
General wellbeing 64.3 ± 34.8 88.1 ± 11.73 88.45 ± 22.06 93.72 ± 15.72 8.52(H) 0.03